Galapagos’ unit, Argenta signs $46m drug discovery deal with Janssen
Galapagos’ acquisition, Argenta, has signed up to a $46m cancer drug discovery service deal with Janssen Pharmaceutica, aimed at delivering novel cancer drug candidates.
Archives for October 5, 2010
Piramal completes Grangemouth ADC expansion
Piramal Healthcare says expanded antibody drug conjugate (ADC) capacity will support 2011 launch of new cancer drug by US biotech partner.